Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Metadata
Title
Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features
Author
Sven Gläsker
Publication date
01-03-2005
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 1/2005
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-004-5347-6

Other articles of this Issue 1/2005

Familial Cancer 1/2005 Go to the issue

OriginalPaper

SDHC mutations in hereditary paraganglioma/pheochromocytoma

OriginalPaper

Multiple endocrine neoplasia type 2

OriginalPaper

Imaging of pheochromocytoma and paraganglioma

OriginalPaper

Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx

Review

Molecular pathogenesis of MEN2-associated tumors

OriginalPaper

Instructions for Authors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits